AI technology along with big data is expected to accelerate clinical trial efficiency through improved patient enrollment and retention, better protocol design, and is also expected to facilitate medical product development and bring more innovations in AI, which is expected to accelerate growth of the global AI-based clinical trials solution provider market. However, stringent regulations associated with approval of AI-based clinical trials is a major factor expected to hamper global AI-based clinical trials solution provider market growth to some extent during the forecast period.

The report studies the impact of the COVID-19 pandemic on the AI-based Clinical Trials Solution Provider market and its crucial segments. The supply chain disruptions and economic instability have negatively impacted the growth of the market in several key regions. The report offers an in-depth analysis of the market size, market share, and market growth and its estimation through the forecast years on the basis of the COVID-19 crisis. The report examines the recent COVID-19 crisis and its impact on the global market. The report explores the present and future impact of the pandemic and provides an insight into the post-pandemic market scenario.

To Get a PDF Sample Copy of the Report, visit @ https://www.emergenresearch.com/request-sample/774

Some Key Highlights From the Report

• Some key players in the market include AiCure, LLC, Unlearn.AI, Inc., BioAge Labs Inc., Antidote Technologies, Inc., Saama Technologies Inc., International Machine Business Corporation (IBM), Concentro Health AI, Deep 6 AI Inc., PathAI Inc., and Owkin Inc.
• In March 2021, Saama Technologies Inc. announced a partnership with Oracle Corporation for integrating Oracle’s Health Science’s Clinical One Platform with Saama’s smart applications. This will enable researchers and clinicians to gain real-time insights and faster outcomes from clinical trials. This partnership will also strengthen Saama’s position as AI-driven Intelligent Clinical Cloud solution provider.
• Contract Research Organizations (CROs) segment is expected to register a significantly robust CAGR in terms of revenue over the forecast period owing to rising implementation of AI-based solutions to improve clinical trial design, increasing number of research studies conducted to develop therapeutics for cardiovascular diseases, cancer, metabolic disorders, Central Nervous System Disorders (CNS), and increasing number of partnerships with biopharmaceutical companies in niche drug discovery.

Request customization of this report @ https://www.emergenresearch.com/request-for-customization/774

ToC of the report:

Chapter 1: Market overview and scope

Chapter 2: Market outlook

Chapter 3: Impact analysis of COVID-19 pandemic

Chapter 4: Competitive Landscape

Chapter 5: Drivers, Constraints, Opportunities, Limitations

Chapter 6: Key manufacturers of the industry

Chapter 7: Regional analysis

Chapter 8: Market segmentation based on type applications

Chapter 9: Current and Future Trends

Emergen Research has segmented the global AI-based clinical trials solution provider market on the basis of clinical trial phase, therapeutic application, end-use, and region:

• Clinical Trial Phase Outlook (Revenue, USD Billion; 2018–2028)
  • Phase-I
  • Phase-II
  • Phase-III
• Therapeutic Application Outlook (Revenue, USD Billion; 2018–2028)
  • Cancer
  • Cardiovascular Disease
  • Neurological Disease
  • Metabolic Disease
  • Infectious Disease
  • Others
• End-use Outlook (Revenue, USD Billion; 2018–2028)
  • Pharmaceuticals
  • Academia
  • Contract Research Organizations (CROs)

• Regional Outlook (Revenue, USD Million; 2018–2028)
• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Spain
• BENELUX
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Rest of APAC
• Latin America
• Brazil
• Rest of LATAM
• Middle East Africa
• Saudi Arabia
• UAE
• South Africa
• Turkey
• Rest of MEA

Gain Access to the Complete Report @ https://www.emergenresearch.com/industry-report/ai-based-clinical-trials-solution-provider-market

Key Questions Answered in the Report:

What is the growth rate of the AI-based Clinical Trials Solution Provider Market?

What is the anticipated market valuation of AI-based Clinical Trials Solution Provider Market industry by 2027?

What are the key growth driving and restraining factors of the AI-based Clinical Trials Solution Provider Market?

Who are the prominent players operating in the market? What are the key strategies adopted by these companies?

What are the key opportunities and growth prospects of the AI-based Clinical Trials Solution Provider Market industry over the forecast period?

Which region is expected to show significant growth in the coming years?

Request a Discount on the Report @ https://www.emergenresearch.com/request-discount/774

Thank you for reading our report. To find more details on the report or to inquire about its customization, please let us know, and we will offer you the report as per your needs.